You are here

BCRF Grantee Since


Donor Recognition

The Play for P.I.N.K. Award

Area(s) of Focus

Fatima Cardoso, MD

European School of Oncology Breast Cancer Program Coordinator
Secretary General, European Organization for Research and Treatment of Cancer
Director, Breast Cancer Unit
Champalimaud Cancer Center
Lisbon, Portugal

Current Research

Male Breast Cancer (BC) is a rare disease accounting for less than 1% of all BC. Knowledge about male BC is scarce, and treatment and management is based on female BC. To better characterize this disease and ultimately develop specific treatments and improve outcomes for men with BC, the Male Breast Cancer International Program was created. Dr. Cardoso is heading up a team of BCRF grantees on this worldwide effort coordinated by the European Organization for the Research and Treatment of Cancer (EORTC), with the help of the Translational Breast Cancer Research Consortium (TBCRC), and run under the network of the Breast International Group (BIG) and the North American Breast Cancer Groups (NABCG). This Program has three parts. Part One is analyzing over 1600 male BC cases treated in the last 20 years to better understand the biology of the disease. This is the largest series of male BC cases ever studied and early results will be presented at the San Antonio Breast Cancer Symposium in 2014. Part Two of the study is focused on creating a registry of all male breast cancer patients treated within the EORTC/TBCRC/BIG/NABCG global network and includes collection of biological material that can be used for future studies. Part Three is a prospective clinical trial that will evaluate a new drug to treat male breast cancer. This program, which includes 23 centers in 9 countries, can exist only due to the continuous and crucial support from BCRF and will lead to the development of better treatment strategies for male breast cancer.


Dr. Cardoso is Director of the Breast Unit of the Champalimaud Cancer Center in Lisbon, Portugal. She earned her medical degree at the University of Porto, Portugal, and completed fellowships at the Jules Bordet Institute (IJB) in Brussels, and the Department of Molecular and Cellular Oncology at MD Anderson Cancer Center. For ten years she was Assistant Professor at the Medical Oncology Clinic of the IJB where, besides her clinical work, she was active in the Translational Research Unit and led phase II-III trials in breast cancer. She is board certified in medical oncology and internal medicine.

Dr. Cardoso’s research interests include biology of breast cancer, prognostic and predictive markers of response to systemic therapy, and new anticancer agents. She is actively involved in phase I-III breast cancer clinical trials and was the scientific director of the international research network TRANSBIG for seven years. She is active in professional organizations such as ESMO, ECCO, EORTC, ASCO, and AACR where she serves on several committees, including EORTC Secretary General and vice-chair of the EORTC-Breast Group. She is the Breast Cancer Program Coordinator of the European School of Oncology and co-chair of the Advanced Breast Cancer International Consensus Guidelines Conference (ABC). She has received educational and research grants from organizations including the Breast Cancer Research Foundation, European Society of Medical Oncology, European Cancer Organization, Portuguese Ministry of Health, Free University of Brussels, Belgian Federation Against Cancer, the Komen Foundation, and the European Union Framework VI Programme. She has authored over 230 publications.